

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.83233257 |
| 2 | neural tube formation (GO:0001841) | 5.80289177 |
| 3 | valine metabolic process (GO:0006573) | 5.55022910 |
| 4 | photoreceptor cell maintenance (GO:0045494) | 5.39338515 |
| 5 | regulation of memory T cell differentiation (GO:0043380) | 5.15737234 |
| 6 | kidney morphogenesis (GO:0060993) | 4.99367423 |
| 7 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.98792048 |
| 8 | termination of RNA polymerase III transcription (GO:0006386) | 4.98792048 |
| 9 | rRNA catabolic process (GO:0016075) | 4.74401486 |
| 10 | nerve growth factor signaling pathway (GO:0038180) | 4.71600672 |
| 11 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.62572873 |
| 12 | DNA deamination (GO:0045006) | 4.52686473 |
| 13 | smooth muscle tissue development (GO:0048745) | 4.39112301 |
| 14 | maturation of 5.8S rRNA (GO:0000460) | 4.33259373 |
| 15 | aggressive behavior (GO:0002118) | 4.27366515 |
| 16 | regulation of gene expression by genetic imprinting (GO:0006349) | 4.27241370 |
| 17 | positive regulation of vasculogenesis (GO:2001214) | 4.01594247 |
| 18 | intra-S DNA damage checkpoint (GO:0031573) | 3.99967143 |
| 19 | relaxation of smooth muscle (GO:0044557) | 3.92697401 |
| 20 | regulation of response to tumor cell (GO:0002834) | 3.92477973 |
| 21 | positive regulation of response to tumor cell (GO:0002836) | 3.92477973 |
| 22 | positive regulation of immune response to tumor cell (GO:0002839) | 3.92477973 |
| 23 | regulation of immune response to tumor cell (GO:0002837) | 3.92477973 |
| 24 | piRNA metabolic process (GO:0034587) | 3.82740908 |
| 25 | I-kappaB phosphorylation (GO:0007252) | 3.77141746 |
| 26 | coenzyme catabolic process (GO:0009109) | 3.65438739 |
| 27 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.60797156 |
| 28 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.60797156 |
| 29 | isotype switching (GO:0045190) | 3.60797156 |
| 30 | forebrain morphogenesis (GO:0048853) | 3.56308896 |
| 31 | response to X-ray (GO:0010165) | 3.52688692 |
| 32 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.52180697 |
| 33 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.52180697 |
| 34 | stress granule assembly (GO:0034063) | 3.50732475 |
| 35 | serotonin receptor signaling pathway (GO:0007210) | 3.48879301 |
| 36 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.48472311 |
| 37 | detection of light stimulus involved in visual perception (GO:0050908) | 3.48472311 |
| 38 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.44895237 |
| 39 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.44895237 |
| 40 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.40349162 |
| 41 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.40349162 |
| 42 | regulation of establishment of cell polarity (GO:2000114) | 3.35100180 |
| 43 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.34602068 |
| 44 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.30834161 |
| 45 | regulation of platelet aggregation (GO:0090330) | 3.26005401 |
| 46 | negative regulation of multicellular organism growth (GO:0040015) | 3.21622678 |
| 47 | negative regulation of protein autophosphorylation (GO:0031953) | 3.19026585 |
| 48 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.17966326 |
| 49 | pseudouridine synthesis (GO:0001522) | 3.16941891 |
| 50 | thrombin receptor signaling pathway (GO:0070493) | 3.16092059 |
| 51 | establishment of protein localization to vacuole (GO:0072666) | 3.15162408 |
| 52 | protein targeting to vacuole (GO:0006623) | 3.15162408 |
| 53 | protein targeting to lysosome (GO:0006622) | 3.15162408 |
| 54 | branched-chain amino acid catabolic process (GO:0009083) | 3.14363285 |
| 55 | negative regulation of necroptotic process (GO:0060546) | 3.12212017 |
| 56 | branched-chain amino acid metabolic process (GO:0009081) | 3.11776810 |
| 57 | response to pheromone (GO:0019236) | 3.10923237 |
| 58 | rRNA modification (GO:0000154) | 3.08075107 |
| 59 | regulation of vasculogenesis (GO:2001212) | 3.07494121 |
| 60 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.05974975 |
| 61 | behavioral response to ethanol (GO:0048149) | 3.02057609 |
| 62 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.01369006 |
| 63 | cellular response to ATP (GO:0071318) | 2.99075136 |
| 64 | indole-containing compound catabolic process (GO:0042436) | 2.90284831 |
| 65 | indolalkylamine catabolic process (GO:0046218) | 2.90284831 |
| 66 | tryptophan catabolic process (GO:0006569) | 2.90284831 |
| 67 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.89844082 |
| 68 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.89844082 |
| 69 | positive regulation of natural killer cell activation (GO:0032816) | 2.86982023 |
| 70 | aromatic amino acid family catabolic process (GO:0009074) | 2.84309784 |
| 71 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.84146573 |
| 72 | DNA methylation involved in gamete generation (GO:0043046) | 2.83576974 |
| 73 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.82501329 |
| 74 | centrosome duplication (GO:0051298) | 2.82260742 |
| 75 | proteasome assembly (GO:0043248) | 2.81395823 |
| 76 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.80088973 |
| 77 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.80088973 |
| 78 | protein import into peroxisome matrix (GO:0016558) | 2.78000521 |
| 79 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.77587857 |
| 80 | L-phenylalanine catabolic process (GO:0006559) | 2.77587857 |
| 81 | somatic diversification of immunoglobulins (GO:0016445) | 2.77419049 |
| 82 | RNA localization (GO:0006403) | 2.76855306 |
| 83 | positive regulation of T cell cytokine production (GO:0002726) | 2.75724863 |
| 84 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.74765241 |
| 85 | positive regulation of prostaglandin secretion (GO:0032308) | 2.74537196 |
| 86 | embryonic epithelial tube formation (GO:0001838) | 2.68853704 |
| 87 | genetic imprinting (GO:0071514) | 2.66985656 |
| 88 | positive regulation of protein homooligomerization (GO:0032464) | 2.65404581 |
| 89 | positive regulation of mRNA catabolic process (GO:0061014) | 2.65157818 |
| 90 | nucleotide transmembrane transport (GO:1901679) | 2.64912522 |
| 91 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.64056220 |
| 92 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.63110689 |
| 93 | defense response to protozoan (GO:0042832) | 2.60807563 |
| 94 | negative regulation of cation channel activity (GO:2001258) | 2.60273905 |
| 95 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.59729005 |
| 96 | regulation of DNA endoreduplication (GO:0032875) | 2.59637730 |
| 97 | tyrosine metabolic process (GO:0006570) | 2.58712720 |
| 98 | regulation of sequestering of triglyceride (GO:0010889) | 2.58690140 |
| 99 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.58600298 |
| 100 | response to nerve growth factor (GO:1990089) | 2.58600298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 4.62991711 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.99845963 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.07239468 |
| 4 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.02257415 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.97432413 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.83725367 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.79554317 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.58845245 |
| 9 | EWS_26573619_Chip-Seq_HEK293_Human | 2.44559536 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.39929034 |
| 11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.33837323 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.16556984 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.11155428 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.09221052 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.01693245 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96898893 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.95321246 |
| 18 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.93310767 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91318255 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.80100228 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.78469782 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.73822463 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.65228995 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.64469970 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61893265 |
| 26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.61715522 |
| 27 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.60954041 |
| 28 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.60954041 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57210396 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55368295 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55277333 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53782355 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51357705 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50039193 |
| 35 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.49682356 |
| 36 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.46428250 |
| 37 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.45257526 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45240447 |
| 39 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.43574237 |
| 40 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.43574237 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40987230 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39709672 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39523920 |
| 44 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.37475793 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36832774 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36094719 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35448975 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34607991 |
| 49 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.31686983 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29296759 |
| 51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28209568 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27066358 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27066358 |
| 54 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.27033973 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26570872 |
| 56 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.22459642 |
| 57 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21138035 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20793263 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20234194 |
| 60 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.17468115 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15670635 |
| 62 | AR_20517297_ChIP-Seq_VCAP_Human | 1.15015895 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13594405 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11716922 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10514661 |
| 66 | GATA3_26560356_Chip-Seq_TH1_Human | 1.10301161 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09835884 |
| 68 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.09010301 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07423722 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06050882 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06036499 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05462696 |
| 73 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05403145 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04377455 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02841738 |
| 76 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.02472428 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02057688 |
| 78 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00601558 |
| 79 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00116241 |
| 80 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.98525472 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98497482 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97922398 |
| 83 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97715778 |
| 84 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.96468764 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96426419 |
| 86 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.95837318 |
| 87 | NFYB_21822215_ChIP-Seq_K562_Human | 0.95782222 |
| 88 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95692578 |
| 89 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.94565479 |
| 90 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93508531 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93260570 |
| 92 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.92627120 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92226509 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92083814 |
| 95 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91507369 |
| 96 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90546022 |
| 97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.90361679 |
| 98 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.90317844 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90274631 |
| 100 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.90267238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003787_abnormal_imprinting | 5.46578913 |
| 2 | MP0003252_abnormal_bile_duct | 3.70892312 |
| 3 | MP0003718_maternal_effect | 3.00257863 |
| 4 | MP0008877_abnormal_DNA_methylation | 2.98475390 |
| 5 | MP0009697_abnormal_copulation | 2.82489551 |
| 6 | MP0004808_abnormal_hematopoietic_stem | 2.64685750 |
| 7 | MP0002254_reproductive_system_inflammat | 2.51962809 |
| 8 | MP0002876_abnormal_thyroid_physiology | 2.44052328 |
| 9 | MP0003011_delayed_dark_adaptation | 2.34879695 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.30411825 |
| 11 | MP0002736_abnormal_nociception_after | 2.28023072 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.27902987 |
| 13 | MP0008058_abnormal_DNA_repair | 2.09695820 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.08252524 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.04593180 |
| 16 | MP0008007_abnormal_cellular_replicative | 1.97829878 |
| 17 | MP0001968_abnormal_touch/_nociception | 1.96466354 |
| 18 | MP0001764_abnormal_homeostasis | 1.93409137 |
| 19 | MP0004147_increased_porphyrin_level | 1.89677957 |
| 20 | MP0002009_preneoplasia | 1.89480963 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.84767698 |
| 22 | MP0005410_abnormal_fertilization | 1.78782766 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.76098291 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.74896955 |
| 25 | MP0006035_abnormal_mitochondrial_morpho | 1.73660355 |
| 26 | MP0004133_heterotaxia | 1.73278187 |
| 27 | MP0005253_abnormal_eye_physiology | 1.68097078 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.58810517 |
| 29 | MP0004130_abnormal_muscle_cell | 1.57083372 |
| 30 | MP0004885_abnormal_endolymph | 1.56914030 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.53226982 |
| 32 | MP0002160_abnormal_reproductive_system | 1.51810750 |
| 33 | MP0002102_abnormal_ear_morphology | 1.48158234 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.45001961 |
| 35 | MP0000685_abnormal_immune_system | 1.44679830 |
| 36 | MP0002928_abnormal_bile_duct | 1.43745446 |
| 37 | MP0000371_diluted_coat_color | 1.38571065 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.37128459 |
| 39 | MP0003121_genomic_imprinting | 1.36707005 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.32496238 |
| 41 | MP0000015_abnormal_ear_pigmentation | 1.31842882 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.31347643 |
| 43 | MP0001188_hyperpigmentation | 1.27158325 |
| 44 | MP0008995_early_reproductive_senescence | 1.26496172 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.21709533 |
| 46 | MP0009046_muscle_twitch | 1.21671390 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.18511236 |
| 48 | MP0003195_calcinosis | 1.18072039 |
| 49 | MP0001661_extended_life_span | 1.17940690 |
| 50 | MP0003786_premature_aging | 1.16429667 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.16236125 |
| 52 | MP0005389_reproductive_system_phenotype | 1.15080698 |
| 53 | MP0005395_other_phenotype | 1.15034339 |
| 54 | MP0003943_abnormal_hepatobiliary_system | 1.14852188 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.13121355 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.10747248 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 1.09523273 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.09388303 |
| 59 | MP0002006_tumorigenesis | 1.06556192 |
| 60 | MP0002693_abnormal_pancreas_physiology | 1.03477499 |
| 61 | MP0000372_irregular_coat_pigmentation | 1.02823905 |
| 62 | MP0002396_abnormal_hematopoietic_system | 1.00660329 |
| 63 | MP0005647_abnormal_sex_gland | 1.00280897 |
| 64 | MP0003329_amyloid_beta_deposits | 1.00189380 |
| 65 | MP0001984_abnormal_olfaction | 0.98801313 |
| 66 | MP0005332_abnormal_amino_acid | 0.97594019 |
| 67 | MP0006082_CNS_inflammation | 0.97200485 |
| 68 | MP0001944_abnormal_pancreas_morphology | 0.95963858 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 0.93447401 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 0.90037487 |
| 71 | MP0001324_abnormal_eye_pigmentation | 0.87609555 |
| 72 | MP0003693_abnormal_embryo_hatching | 0.84448371 |
| 73 | MP0001346_abnormal_lacrimal_gland | 0.82880182 |
| 74 | MP0006292_abnormal_olfactory_placode | 0.82538581 |
| 75 | MP0001879_abnormal_lymphatic_vessel | 0.82471740 |
| 76 | MP0002163_abnormal_gland_morphology | 0.82178390 |
| 77 | MP0008872_abnormal_physiological_respon | 0.81392558 |
| 78 | MP0003283_abnormal_digestive_organ | 0.73836328 |
| 79 | MP0001119_abnormal_female_reproductive | 0.73550327 |
| 80 | MP0001502_abnormal_circadian_rhythm | 0.72961590 |
| 81 | MP0009745_abnormal_behavioral_response | 0.72662826 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.67298699 |
| 83 | MP0000604_amyloidosis | 0.67225124 |
| 84 | MP0000689_abnormal_spleen_morphology | 0.64893060 |
| 85 | MP0002733_abnormal_thermal_nociception | 0.64188728 |
| 86 | MP0005535_abnormal_body_temperature | 0.64089841 |
| 87 | MP0005195_abnormal_posterior_eye | 0.64064769 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.63126362 |
| 89 | MP0003633_abnormal_nervous_system | 0.62920154 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.62370435 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.61062125 |
| 92 | MP0008770_decreased_survivor_rate | 0.60768831 |
| 93 | MP0000653_abnormal_sex_gland | 0.60461963 |
| 94 | MP0008775_abnormal_heart_ventricle | 0.59336861 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.58135115 |
| 96 | MP0003646_muscle_fatigue | 0.57404659 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 0.56978244 |
| 98 | MP0001664_abnormal_digestion | 0.56760696 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.56670829 |
| 100 | MP0002229_neurodegeneration | 0.56345505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous abortion (HP:0005268) | 5.73111243 |
| 2 | Stomatitis (HP:0010280) | 5.12187362 |
| 3 | Abnormality of the renal cortex (HP:0011035) | 4.56877142 |
| 4 | Hypoplastic pelvis (HP:0008839) | 4.29543148 |
| 5 | Genetic anticipation (HP:0003743) | 4.10175066 |
| 6 | Renal cortical cysts (HP:0000803) | 3.89396825 |
| 7 | Abnormal biliary tract physiology (HP:0012439) | 3.85939113 |
| 8 | Bile duct proliferation (HP:0001408) | 3.85939113 |
| 9 | Abnormality of the renal medulla (HP:0100957) | 3.74452207 |
| 10 | Supernumerary spleens (HP:0009799) | 3.73750970 |
| 11 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 3.66035268 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.57209318 |
| 13 | Pancreatic cysts (HP:0001737) | 3.55950274 |
| 14 | Hyperglycemia (HP:0003074) | 3.54550658 |
| 15 | Asplenia (HP:0001746) | 3.53063908 |
| 16 | Tubular atrophy (HP:0000092) | 3.42591573 |
| 17 | Enlarged kidneys (HP:0000105) | 3.42524560 |
| 18 | Thrombocytosis (HP:0001894) | 3.35147180 |
| 19 | Nephronophthisis (HP:0000090) | 3.32467960 |
| 20 | Abnormal drinking behavior (HP:0030082) | 3.31373064 |
| 21 | Polydipsia (HP:0001959) | 3.31373064 |
| 22 | Menstrual irregularities (HP:0000858) | 3.27244335 |
| 23 | Increased IgM level (HP:0003496) | 3.25646980 |
| 24 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.25484433 |
| 25 | Abolished electroretinogram (ERG) (HP:0000550) | 3.22686283 |
| 26 | Prostate neoplasm (HP:0100787) | 3.05854184 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 3.01440942 |
| 28 | Congenital stationary night blindness (HP:0007642) | 2.95968197 |
| 29 | Abnormal biliary tract morphology (HP:0012440) | 2.87590100 |
| 30 | Abnormality of macular pigmentation (HP:0008002) | 2.85508576 |
| 31 | Hypoplastic iliac wings (HP:0002866) | 2.85218881 |
| 32 | Central scotoma (HP:0000603) | 2.85015234 |
| 33 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.81953232 |
| 34 | Abnormality of the hepatic vasculature (HP:0006707) | 2.81429225 |
| 35 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.80477361 |
| 36 | Dry hair (HP:0011359) | 2.75583558 |
| 37 | Abnormal delivery (HP:0001787) | 2.75392258 |
| 38 | Hyperglycinuria (HP:0003108) | 2.71659101 |
| 39 | Tinnitus (HP:0000360) | 2.70418191 |
| 40 | Facial shape deformation (HP:0011334) | 2.69361776 |
| 41 | Potter facies (HP:0002009) | 2.69361776 |
| 42 | Widely patent fontanelles and sutures (HP:0004492) | 2.68607133 |
| 43 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.67015386 |
| 44 | Hypoplasia of the fovea (HP:0007750) | 2.67015386 |
| 45 | Amaurosis fugax (HP:0100576) | 2.66561889 |
| 46 | Progressive inability to walk (HP:0002505) | 2.65802391 |
| 47 | Breech presentation (HP:0001623) | 2.59353079 |
| 48 | Arterial thrombosis (HP:0004420) | 2.58239038 |
| 49 | Cystic liver disease (HP:0006706) | 2.56829279 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.54790187 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.52616949 |
| 52 | Facial diplegia (HP:0001349) | 2.52235505 |
| 53 | Severe visual impairment (HP:0001141) | 2.50686408 |
| 54 | Posterior subcapsular cataract (HP:0007787) | 2.50024823 |
| 55 | Hyperglycinemia (HP:0002154) | 2.49525248 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.47838927 |
| 57 | Decreased lacrimation (HP:0000633) | 2.47763585 |
| 58 | Pendular nystagmus (HP:0012043) | 2.44640748 |
| 59 | Abnormal auditory evoked potentials (HP:0006958) | 2.44600513 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.43059351 |
| 61 | Tubulointerstitial abnormality (HP:0001969) | 2.40360797 |
| 62 | Protruding tongue (HP:0010808) | 2.36427372 |
| 63 | Tubulointerstitial fibrosis (HP:0005576) | 2.34986765 |
| 64 | Impulsivity (HP:0100710) | 2.34588741 |
| 65 | Polyuria (HP:0000103) | 2.33863052 |
| 66 | Dysmetric saccades (HP:0000641) | 2.32218447 |
| 67 | Azoospermia (HP:0000027) | 2.28307746 |
| 68 | Anhidrosis (HP:0000970) | 2.26330358 |
| 69 | Clumsiness (HP:0002312) | 2.22186382 |
| 70 | Hypochromic anemia (HP:0001931) | 2.17618086 |
| 71 | Ileus (HP:0002595) | 2.14352425 |
| 72 | Delayed gross motor development (HP:0002194) | 2.13843867 |
| 73 | Chorioretinal atrophy (HP:0000533) | 2.12835420 |
| 74 | Congenital hepatic fibrosis (HP:0002612) | 2.09002665 |
| 75 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.08706317 |
| 76 | Adrenal hypoplasia (HP:0000835) | 2.07603546 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.06442681 |
| 78 | Gaze-evoked nystagmus (HP:0000640) | 2.06362316 |
| 79 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.05963882 |
| 80 | Cerebellar dysplasia (HP:0007033) | 2.05658844 |
| 81 | Redundant skin (HP:0001582) | 2.05032051 |
| 82 | Abnormality of the fovea (HP:0000493) | 2.04638480 |
| 83 | Decreased central vision (HP:0007663) | 2.04429072 |
| 84 | Portal hypertension (HP:0001409) | 2.03213064 |
| 85 | Bell-shaped thorax (HP:0001591) | 2.02277118 |
| 86 | Hypophosphatemic rickets (HP:0004912) | 2.02228925 |
| 87 | Inability to walk (HP:0002540) | 1.99144697 |
| 88 | Tubulointerstitial nephritis (HP:0001970) | 1.98569642 |
| 89 | Abnormality of the nasal septum (HP:0000419) | 1.97053622 |
| 90 | Decreased skull ossification (HP:0004331) | 1.95536981 |
| 91 | Abnormal spermatogenesis (HP:0008669) | 1.94274430 |
| 92 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93902855 |
| 93 | Action tremor (HP:0002345) | 1.92779258 |
| 94 | Flat occiput (HP:0005469) | 1.92395157 |
| 95 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.92020236 |
| 96 | Postural tremor (HP:0002174) | 1.90667628 |
| 97 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.88598562 |
| 98 | IgM deficiency (HP:0002850) | 1.87899067 |
| 99 | Testicular atrophy (HP:0000029) | 1.87283142 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.84519016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 6.52983783 |
| 2 | FRK | 5.61789957 |
| 3 | PBK | 4.02167379 |
| 4 | PINK1 | 3.49783305 |
| 5 | MAP3K7 | 3.20528053 |
| 6 | MAP3K14 | 2.63833183 |
| 7 | CDK19 | 2.36415880 |
| 8 | OXSR1 | 2.33145800 |
| 9 | BCKDK | 2.19064290 |
| 10 | ZAK | 2.10446163 |
| 11 | VRK1 | 1.98051554 |
| 12 | GRK1 | 1.94483745 |
| 13 | BRSK2 | 1.90070667 |
| 14 | FGFR2 | 1.76602758 |
| 15 | PRKG2 | 1.64444235 |
| 16 | MKNK1 | 1.61219731 |
| 17 | NUAK1 | 1.58375651 |
| 18 | WNK4 | 1.57742725 |
| 19 | MKNK2 | 1.52442669 |
| 20 | ADRBK2 | 1.44682231 |
| 21 | CAMKK2 | 1.40058228 |
| 22 | TAOK3 | 1.38576536 |
| 23 | MAP4K2 | 1.32549604 |
| 24 | BMPR1B | 1.32278600 |
| 25 | PIK3CA | 1.26061844 |
| 26 | CSNK1G2 | 1.23590530 |
| 27 | AKT3 | 1.22866857 |
| 28 | GRK6 | 1.19905141 |
| 29 | CSNK1A1L | 1.19721158 |
| 30 | PLK3 | 1.17130019 |
| 31 | RPS6KB2 | 1.11254840 |
| 32 | PRKCQ | 1.10902388 |
| 33 | CSNK1G3 | 1.09091623 |
| 34 | CSNK1G1 | 1.05327333 |
| 35 | TXK | 1.04165297 |
| 36 | MAPKAPK3 | 1.04089675 |
| 37 | ACVR1B | 1.02690853 |
| 38 | PRKCE | 0.95645503 |
| 39 | TGFBR1 | 0.91339620 |
| 40 | SYK | 0.88030993 |
| 41 | PHKG2 | 0.87914316 |
| 42 | PHKG1 | 0.87914316 |
| 43 | LATS1 | 0.87281690 |
| 44 | NME2 | 0.85240120 |
| 45 | TGFBR2 | 0.82986873 |
| 46 | BTK | 0.79884567 |
| 47 | FGFR3 | 0.77254608 |
| 48 | TEC | 0.76509738 |
| 49 | MAP4K1 | 0.68213391 |
| 50 | TNK2 | 0.67208129 |
| 51 | MAP2K6 | 0.66253345 |
| 52 | JAK3 | 0.65442014 |
| 53 | DAPK2 | 0.64692008 |
| 54 | MAPKAPK5 | 0.63302885 |
| 55 | PRKAA2 | 0.60812410 |
| 56 | PRKG1 | 0.58938602 |
| 57 | KIT | 0.58574589 |
| 58 | CHEK2 | 0.58426836 |
| 59 | BCR | 0.57814248 |
| 60 | IKBKB | 0.56988395 |
| 61 | TIE1 | 0.56695111 |
| 62 | RPS6KA5 | 0.55356316 |
| 63 | PLK2 | 0.50281984 |
| 64 | STK39 | 0.49778473 |
| 65 | STK38L | 0.47627092 |
| 66 | HCK | 0.47003091 |
| 67 | PTK2B | 0.46865255 |
| 68 | STK3 | 0.46236972 |
| 69 | CHUK | 0.44496311 |
| 70 | ADRBK1 | 0.43967678 |
| 71 | STK24 | 0.43198238 |
| 72 | YES1 | 0.41928237 |
| 73 | ITK | 0.41912025 |
| 74 | TRPM7 | 0.40714893 |
| 75 | PRKCG | 0.40253010 |
| 76 | RPS6KB1 | 0.39890725 |
| 77 | MAPK11 | 0.38474695 |
| 78 | FES | 0.38203999 |
| 79 | IKBKE | 0.37795747 |
| 80 | WNK3 | 0.37173454 |
| 81 | CSNK1D | 0.36831241 |
| 82 | OBSCN | 0.36781438 |
| 83 | MATK | 0.36364961 |
| 84 | GRK7 | 0.36294841 |
| 85 | FER | 0.33577030 |
| 86 | TLK1 | 0.32222459 |
| 87 | PRKCD | 0.32020753 |
| 88 | SGK1 | 0.31765396 |
| 89 | LCK | 0.30884939 |
| 90 | GRK5 | 0.30111406 |
| 91 | CSK | 0.27178703 |
| 92 | CHEK1 | 0.25386937 |
| 93 | LYN | 0.25013496 |
| 94 | PRKCA | 0.24518133 |
| 95 | CDK3 | 0.24404553 |
| 96 | PRKCI | 0.23576374 |
| 97 | MAPK9 | 0.23320992 |
| 98 | CSF1R | 0.22327061 |
| 99 | PDK1 | 0.22319358 |
| 100 | ATM | 0.20950344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RNA polymerase_Homo sapiens_hsa03020 | 3.60208974 |
| 2 | Selenocompound metabolism_Homo sapiens_hsa00450 | 3.15921161 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.72386487 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.65043090 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.48988781 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.46773950 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.27704919 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.14803315 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.08567964 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.96990946 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.93398544 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85339938 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85053367 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.81117741 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.76599128 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.74793593 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.74716795 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70703277 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.62570526 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.61634612 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.48925216 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45036534 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.44082634 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43473776 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42307901 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41327696 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.36849917 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35407975 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.35244318 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.31853753 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.25957895 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24580779 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23909900 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.22544822 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19880681 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.19186749 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17145726 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.16843065 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15056902 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.14128707 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.13779213 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12704919 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12532603 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.12312596 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12238627 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12181954 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10910346 |
| 48 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.09671097 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06773221 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03167617 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.02174110 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99504043 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 0.98091679 |
| 54 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.97908490 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 0.97360041 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94925704 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94753746 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.89153321 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.87514008 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.85948464 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84773868 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84000384 |
| 63 | Purine metabolism_Homo sapiens_hsa00230 | 0.82159411 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79684461 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.77851069 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76943346 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76797213 |
| 68 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.75827309 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75381282 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71086400 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69442788 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67468156 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66078106 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58698938 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57320008 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56254727 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.55279062 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54744273 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51172998 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50849679 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47888867 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47795948 |
| 83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46908309 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46768289 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45548424 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44091176 |
| 87 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.44034757 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43464392 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38245454 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.37825873 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33696553 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.33158973 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32159230 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28788250 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28691513 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27205083 |
| 97 | Melanoma_Homo sapiens_hsa05218 | 0.25543791 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24554584 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.23288059 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21154790 |

